Clinical Trials Sponsored by Caretech Innovation

Total 2076 results

NasaClip
Emergency Medical Innovations, LLC

Recruiting

Nasal Compression Device Study for Epistaxis

Epistaxis Nosebleed

United States
SCRI Development Innovations, LLC
Amgen

Completed

Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers

Neuroendocrine Cancer

United States
Andreas Nikolis

Completed

BOTOX® Cosmetic and Skin Health.

Oily Skin

Canada
SCRI Development Innovations, LLC
Celgene

Completed

Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer

Metastatic Breast Cancer

United States
SCRI Development Innovations, LLC
Bayer

Completed

Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Novartis

Completed

LBH589 Treatment for Refractory Clear Cell Renal Carcinoma

Renal Cell Carcinoma

United States
SCRI Development Innovations, LLC
Sanofi

Completed

Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer

Breast Cancer

United States
SCRI Development Innovations, LLC
Pfizer

Completed

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

Colorectal Cancer

United States
SCRI Development Innovations, LLC
Novartis

Completed

Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib

Non Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Novartis

Withdrawn

Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel

Advanced Prostate Cancer

United States
Ology Bioservices
Baxter Innovations GmbH

Completed

H5N1 Vaccine Study in Japanese Adults

H5N1 Influenza

Japan
SCRI Development Innovations, LLC
Amgen

Completed

FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

Colorectal Cancer

United States
SCRI Development Innovations, LLC
Novartis

Completed

Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors

Malignant Solid Tumour

United States
SCRI Development Innovations, LLC
Bayer

Completed

Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer

Ovarian Cancer

United States
SCRI Development Innovations, LLC
Bayer

Completed

PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid Tumors

Refractory Solid Tumors

United States
SCRI Development Innovations, LLC
Novartis

Completed

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

Metastatic Melanoma

United States
SCRI Development Innovations, LLC
Bayer

Completed

Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma

Renal Cell Carcinoma

United States
SCRI Development Innovations, LLC
Novartis

Terminated

LBH589 and Gemcitabine in the Treatment of Solid Tumors

Solid Tumors

United States
SCRI Development Innovations, LLC
Novartis

Completed

Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors

Solid Tumors | Refractory Malignancy

United States
SCRI Development Innovations, LLC
GlaxoSmithKline

Completed

Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer

Small Cell Lung Cancer | Carcinoma, Small Cell

United States
SCRI Development Innovations, LLC
GlaxoSmithKline

Completed

Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors

Cancer

United States
SCRI Development Innovations, LLC
AstraZeneca

Completed

Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer

Lung Cancer
SCRI Development Innovations, LLC
Biogen

Completed

Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's Lymphoma

Non-Hodgkins Lymphoma
SCRI Development Innovations, LLC
Novartis

Completed

LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors

Solid Tumors

United States
SCRI Development Innovations, LLC
Bayer

Completed

Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Non-Hodgkins Lymphoma
SCRI Development Innovations, LLC
Pfizer

Completed

Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting

Gastrointestinal Stromal Tumors

United States
Fenix Innovation Group
Monash Health; Neurotech International

Not yet recruiting

Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder

Autism Spectrum Disorder

Australia
GI Innovation, Inc.
Merck Sharp & Dohme LLC

Recruiting

GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors

Melanoma | Sarcoma | Renal Cell Carcinoma | Cervical Cancer | Urinary Bladder Cancer | Vulvar Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Merkel Cell Carcinoma | Vaginal Cancer | Microsatellite Stable...

Korea, Republic of, United States
Christian Riberholt
SENS Innovation Aps

Active, not recruiting

Mobility and Activity Patterns in Hospitalised Severe Brain Injury (MAP-ABI)

Brain Injuries

Denmark
Otsuka Holdings Co., Ltd.
Biofortis Innovation Services

Completed

A Study Investigating the Effects of a Novel Mindfulness Approach on Frequency and Duration of Meditation and Self-Reported Stress and Mood in Generally Healthy Adults

Health Knowledge, Attitudes, Practice

United States
University of Phayao
National Innovation Agency (NIA)

Completed

Effect of Cordyceps Militaris Beverage on the Immune Response

Healthy

Thailand
Carilion Clinic
Virginia Center for Health Innovation

Enrolling by invitation

Quality Improvement re: Choosing Wisely Back Pain Measures (SCV LBP)

Back Pain | Back Pain Lower Back Chronic | Back Pain, Low

United States
Curacle Co., Ltd.
Théa Open Innovation, France

Active, not recruiting

The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME)

Diabetic Macular Edema

United States, Puerto Rico
Universite de Moncton
New Brunswick Innovation Foundation

Completed

Effectiveness of the Apprenti en Action School-based Culinary Program on 9-10-year-old Children's Food Literacy

Eating Behavior | Fruit and Vegetable Intake

Canada
Fenix Innovation Group
Monash Health; Neurotech International

Active, not recruiting

Safety and Efficacy of Oral Full-Spectrum Medicinal Cannabis Plant Extract in Children With Autism Spectrum Disorder.

Autism Spectrum Disorder

Australia
SQ Innovation, Inc.
EB Medical Research; Quartesian

Completed

A Safety/Tolerance Phase, Ascending Single Dose Study to Evaluate the Safety and Tolerability of G3P-01, a Food-Grade Pectic Product, in Healthy Volunteers (G3P-01-01)

Gastrointestinal Discomfort | Performance Status

Netherlands
Jewish General Hospital
Exactis Innovation; Genome Quebec

Completed

Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients

Triple Negative Breast Cancer

Canada, United States
Dayzz Live Well Ltd.
Israel Innovation Authority

Completed

Validation of the Dayzz Digital Sleep Training App in Insomnia and Sleep Apnea

Insomnia | Sleep Apnea

Israel
Indonesia University
PT Paragon Technology and Innovation

Completed

Sun Protection Factor (SPF) / UVA Protection Factor Study

Sunscreen Agents

Indonesia
SQ Innovation, Inc.
Community Clinical Research Network

Completed

An Open-label, Non Significant Risk, Adhesive Wear Validation Study for the On Body Drug Delivery Device Component of the SQIN-01 Furosemide Infusor (Infusor Device)

Healthy Volunteer Study

United States
Duke University
Duke Institute for Health Innovation

Completed

Cancer Distress Coach Mobile App Trial

Cancer | Posttraumatic Stress Disorder

United States
SOM Innovation Biotech SA
Hospital Vall d'Hebron

Completed

Study of SOM0226 in Familial Amyloid Polyneuropathy

Familial Amyloid Polyneuropathy (FAP)

Spain
University of Guelph
Bunge Global Innovation Incorporated

Completed

Millet Products Study - Investigation of Glycemic Index and Satiety

Hyperglycemia | Lack of Satiety

Canada
QualiMed Innovative Medizinprodukte GmbH

Recruiting

A PROSPECTIVE, MULTI-CENTER, SINGLE-ARM, POST MARKET OBSERVATIONAL STUDY TO EVALUATE THE SAFETY AND CLINICAL PERFORMANCE OF THE ARCHIMEDES BIODEGRADABLE BILIARY AND PANCREATIC STENT (AM GI Registry)

Obstructed Biliary and Pancreatic Duct

Spain, Israel, Finland, Italy, Slovenia, Germany
Boston Children's Hospital
Innovision

Completed

Validation of a Novel Oxygen Consumption Measurement Technique in Neonates

Congenital Heart Defect | Neonatal Respiratory Failure

United States
French Innovative Leukemia Organisation

Terminated

Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL (BOMP)

B-cell Chronic Lymphocytic Leukemia (B-CLL)

France
French Innovative Leukemia Organisation

Terminated

Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

Lymphoma

France
French Innovative Leukemia Organisation

Completed

Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP

Leukemia

France
Oculus Innovative Sciences, Inc.

Unknown

A Substantial Equivalence Study of RD04723 and Predicate Device

Hypertrophic Scar | Keloid Scar

United States
French Innovative Leukemia Organisation

Completed

Phase III Study Treatment of CLL B and C

Leukemia, Lymphocytic, Chronic

Clinical Trials Sponsored by Caretech Innovation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations